FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Oxybutynin Chloride Extended-Release Tablets
Status: Discontinuation
»Therapeutic Categories: Neurology; Pediatric; Urology

Expand all

Impax Laboratories (New 03/29/2019)

Company Contact Information:
877-835-5472

Presentation Posting Date Related Information
5 mg, 100 count bottle (NDC 0093-5206-01) 03/29/2019 Distributed by Teva Pharmaceuticals, 1-800-545-8800. Teva made a business decision to discontinue product.
10 mg, 100 count bottle (NDC 0093-5207-01) 03/29/2019 Distributed by Teva Pharmaceuticals, 1-800-545-8800. Teva made a business decision to discontinue product.
15 mg, 100 count bottle (NDC 0093-5208-01) 03/29/2019 Distributed by Teva Pharmaceuticals, 1-800-545-8800. Teva made a business decision to discontinue product.

Mylan Pharmaceuticals Inc. (New 05/02/2019)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
5 mg, 100 count bottle (NDC 0378-6605-01) 05/02/2019
5 mg, 500 count bottle (NDC 0378-6605-05) 05/02/2019
10 mg, 100 count bottle (NDC 0378-6610-01) 05/02/2019
10 mg, 500 count bottle (NDC 0378-6610-05) 05/02/2019
15 mg, 100 count bottle (NDC 0378-6615-01) 05/02/2019

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English